Ellen Snow
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ellen Snow
Ellen Snow is recorded as CFO at Akebia Therapeutics, Inc. (AKBA). Akebia Therapeutics, Inc. reported in an 8-K filed March 15, 2024 that Ellen Snow resigned as Senior Vice President, Chief Financial Officer and Treasurer, effective March 22, 2024. Akebia Therapeutics, Inc. reported in an 8-K filed June 13, 2023 that Ellen Snow was appointed Senior Vice President, Chief Financial Officer, Treasurer, principal financial officer and principal accounting officer, effective July 17, 2023. The proxy statement of Akebia Therapeutics, Inc. reports total compensation of $1,048,621 for Ellen Snow in fiscal 2024, including a base salary of $99,641. Disclosed compensation is on record for 2 fiscal years. Ellen Snow has spoken on 1 earnings call across 1 company, most recently for Akebia Therapeutics, Inc. on November 8, 2023.
“On March 15, 2024, Akebia Therapeutics, Inc. (the "Company") and Ellen Snow mutually agreed that she would transition from her role as the Company's Senior Vice President, Chief Financial Officer and Treasurer, effective March 22, 2024 (the "Transition Date").”
“On June 12, 2023, the Company announced that Ellen Snow will succeed Mr. Spellman as the Company's Senior Vice President, Chief Financial Officer, Treasurer, principal financial officer and principal accounting officer, effective July 17, 2023 (the "Effective Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-07-17–present
-
Start not stated–2024-03-22
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Akebia Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- John Butler CEO, CFO, Board Member
- John P. Butler CEO, Board Member
- Erik Ostrowski CFO
- David A. Spellman Chief Accounting Officer
- Richard C. Malabre Chief Accounting Officer
- Adrian Adams Board Member
- LeAnne M. Zumwalt Board Member
- Michael Rogers Board Member
- Myles Wolf, M.D., M.M.Sc. Board Member
- Myles Wolf, M.D., M.S.Sc. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Akebia Therapeutics, Inc. (AKBA) | Former Senior Vice President, Chief Financial Officer and Treasurer | $99,641 | $1,048,621 |
| 2023 | Akebia Therapeutics, Inc. (AKBA) | Former Senior Vice President, Chief Financial Officer and Treasurer | $216,346 | $1,715,814 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.